Author

A. Marks

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

B. D. Brown· 2 shared M. Merad· 2 shared A. Baccarini· 1 shared A. J. Kaufman· 1 shared A. Lakshmi· 1 shared A. M. Tsankov· 1 shared A. Magen· 1 shared A. R. Sanchez-Paulete· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. D. Brown

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumors

S. Hegde, B. Giotti, B. Y. Soong, L. Halasz, J. Le Berichel, A. Magen, B. Kloeckner, R. Mattiuz, M. D. Park, A. Marks, M. Belabed, P. Hamon, T. Chin, L. Troncoso, J. J. Lee, , M. Merad

The paper identifies NRF2-driven myeloid progenitor dysregulation that sustains immunosuppressive macrophages in tumors, showing NRF2 inhibition reduces their survival and enhances antitumor immunity.

bioRxiv · Jun 24, 2024Immunology

Targeting macrophages with CAR-T cells delays solid tumor progression and enhances anti-tumor immunity

A. R. Sanchez-Paulete, J. Mateus-Tique, G. Mollaoglu, S. R. Nielsen, A. Marks, A. Lakshmi, L. Pia, A. Baccarini, M. Merad, B. D. Brown

This study shows that CAR-T cells targeting macrophages delay tumor growth and improve survival in mouse models of solid tumors by enhancing anti-tumor immunity.

bioRxiv · Dec 17, 2021Immunology